Point72 Asia (Singapore) Pte. Ltd. Aclaris Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 48,187 shares of ACRS stock, worth $112,275. This represents 0.03% of its overall portfolio holdings.
Number of Shares
48,187
Previous 52,052
7.43%
Holding current value
$112,275
Previous $59.9 Million
99.64%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ACRS
# of Institutions
107Shares Held
88.1MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.2 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.4 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.7 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$14.5 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.9 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $155M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...